surmount-1 tirzepatide trial obesity without diabetes Demonstrates 94% Reduction, 22% Weight Loss in SURMOUNT -1 Study Gastrointestinal tolerability and weight reduction
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


























